TrianglePUBLICATIONS · 37914801
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Cancer
- Publication date
- 2023 Dec
- First author
- Duffaud F
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Duffaud F
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Chevreau C
- type
- Author
- name
- Boudou-Rouquette P
- type
- Author
- name
- Kalbacher E
- type
- Author
- name
- Penel N
- type
- Author
- name
- Perrin C
- type
- Author
- name
- Laurence V
- type
- Author
- name
- Bompas E
- type
- Author
- name
- Saada-Bouzid E
- type
- Author
- name
- Delcambre C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Duffaud F
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Chevreau C
- type
- Author
- name
- Boudou-Rouquette P
- type
- Author
- name
- Kalbacher E
- type
- Author
- name
- Penel N
- type
- Author
- name
- Perrin C
- type
- Author
- name
- Laurence V
- type
- Author
- name
- Bompas E
- type
- Author
- name
- Saada-Bouzid E
- type
- Author
- name
- Delcambre C
- type
- Author
- bibliography ids
- nci-bib-1b4fddbc17f95c05dc710019
- book metadata
- content sha256
- a3efa9bd9e660fa0a2dda4273297476fa29581e2ec247c7e0669afb339394866
- document type
- citation
- dois
- 10.1038/s41416-023-02413-9
- electronic publication date
- display
- 2023 Nov 1
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37914801
- immutable id
- pubmed:37914801@a3efa9bd9e660fa0a2dda4273297476fa29581e2ec247c7e0669afb339394866
- journal
- abbreviation
- Br J Cancer
- issn electronic
- 1532-1827
- issn print
- 0007-0920
- issue
- 12
- name
- British journal of cancer
- nlm unique id
- 0370635
- pages
- 1940-1948
- volume
- 129
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37914801
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- d49a26097112461acd048b556c7c3a6d25517f021b5229b5fc9b02670962f345
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2023 Dec
- precision
- month
- year
- 2023
- publication types
- Randomized Controlled Trial
- Multicenter Study
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Preserved source evidence · Not medical advice